in order to produce a composition of biological cells and / or tissue in accordance with the invention , according to fig1 , at first the stem cells isolated from a donor organism are provided ( step 100 ), subsequently they aggregate to organoid bodies ( step 200 ) that are subjected to a differentiation and / or to a growth ( step 300 ) and finally to a collection and further processing , especially propagation ( step 400 ). although the steps 100 and 200 substantially comprise the aggregation step in accordance with the invention , whereas the steps 300 and 400 substantially represent the differentiation step in accordance with the invention and these two complexes are discussed separately in the following , it is stressed that partial steps of the differentiation may take place already within the framework of the aggregation and , vice versa , partial steps of the aggregation may be realized at first within the framework of the preparation . thus , e . g ., the differentiation of the organoid bodies may begin within the framework of the aggregation already or isolated stem cells can aggregate with organoid bodies that had already been pre - differentiated . the embodiments of the invention explained in the following refer by way of example to the production of the biological material composition from stem cells removed from rats or humans . however , the implementation of the invention is not limited to these organisms but rather the corresponding processes can be realized with all organisms with differentiated exocrine glands with acinar tissue thus , e . g ., with fish that have acinar tissue on the pancreas gland or mammals such as , e . g ., cattle or sheep . ( i ) aggregation of stem cells from a differentiated exocrine gland of a living organism to organoid bodies and / or tissue bodies according to the scheme shown in fig2 , in order to obtain the cells acinar tissue , preferably from a salivary gland or the salivary gland of the abdomen ( pancreas ), is received in culture in a mechanically and enzymatically comminuted form ( step 10 in fig2 ). contrary to the indications of bachem et al ., gastroenterol . 115 : 421 - 432 ( 1998 ) and grosfils et al ., res . comm . chem . path . pharmacol . 79 : 99 - 115 ( 1993 ) no tissue blocks are cultivated from which cells are supposed to grow but rather the tissue is comminuted more strongly , with the proviso that the cell aggregations of the acini remain intact to the greatest extent possible . these cells and cell aggregations are cultivated in culture vessels for several weeks . every 2 to 3 days , the medium is changed , all differentiated cells being removed . the cells persisting in culture are non - differentiated cells with an unlimited capacity for division . similar cells have been isolated and described under the same conditions from the pancreas and designated as a type of myofibroblasts and pancreatic star cells ( bachem et al ., 1998 ). however , in contrast to the cells of the present invention an unlimited ability to divide could not be observed . furthermore , these cells were also not able to be passaged in an unlimited manner without loosing vitality . in a second step ( 12 ) approximately 400 to 800 cells are cultivated in 20 μl medium in suspended drops . to this end the drops are placed on covers of bacteriological petri dishes , turned upside down and placed over the petri dish filled with medium so that the drops hang downward . as a result of this type of cultivation cell aggregates ( 14 ) designated as organoid bodies form within 48 h and are transferred into a suspension culture for approximately 6 days ( 16 ). the partial view ( 18 ) in fig2 shows a microscopic photograph of such an organoid body 2 . the various possibilities of providing organoid bodies as starting materials for further differentiation are compiled with further details in fig3 . the aggregation to the so - called primary organoid bodies ( step 220 ) takes place after the above - described cultivation of the isolated stem cells in hanging drops ( step 210 ), which primary organoid bodies can be subjected directly to the differentiation and the growth ( step 300 in fig1 ). as an alternative , the depositing of the primary organoid bodies on a substrate ( step 230 ) takes place at first for creating an adhesion culture ( see fig4 also ). the inventors observed that the primary organoid bodies growing in suspension culture can form new organoid bodies in adhesion culture . the formation of a monolayer ( step 240 ) on the substrate by cell migration follows and from this monolayer the aggregation to the so - called secondary organoid bodies follows ( step 250 ). the latter can be subjected directly to the further differentiation and / or the growth ( step 300 ). the formation of the secondary organoid bodies is also illustrated in fig4 . primary organoid bodies 2 first form a monolayer on the substrate of the adhesion culture such as e . g ., on the bottom of culture dish 20 by a migration or growth of cells 3 from which monolayer then secondary organoid bodies 4 grow out . a further multiplication of the biomaterial is generated with the cultivation of primary organoid bodies 2 to secondary organoid bodies 4 . tissue bodies can grow from each of the primary or secondary organoid bodies 2 , 4 during further cultivation . the isolation and aggregation of stem cells is explained in detail in the following non - limiting examples . the general working instructions customary for processes for cultivating biological cells and in particular mammalian cells are to be observed . a sterile environment in which the process is to be carried out is to be maintained in any case , even if no further description for this is given . the following buffers and media were used : instead of fetal calf serum ( fcs ) in the culture medium and differentiation medium autoplasma , or , less preferably , autoserum of the tissue donor may also be used as an option . this is especially significant when the tissue donor is identical with the subsequent recipient of the stem cells or differentiated cells derived therefrom . such an autologous treatment is preferred in order to prevent a possible rejection reaction . instead of the dmem medium used , the culture medium may also contain another known basic medium suitable for the cultivation of eukaryotic cells , especially mammalian cells , as basic medium in which the differentiated cells die and the desired stem cells propagate . the isolation medium , incubation medium and differentiation medium may also contain another customary and suitable basic medium . the following examples 1 and 2 describe in detail two working protocols for isolating and cultivating adult pluripotent stem cells from acinar tissue of the pancreas . example 3 describes a corresponding protocol for the isolation from acinar tissue of the salivary gland . using a syringe and a blunt cannula , 10 ml digestion medium was injected slowly and without bubbles into the pancreatic duct of two - to three - year - old rats . the entire pancreas is inflated by this procedure and thus , can be removed and prepared more easily . the pancreas is then transferred to a glass beaker and another 5 ml digestion medium is added . after removing the fatty tissue and lymph nodes , the tissue is divided very finely in the glass beaker using fine scissors , fatty tissue floating at the top is removed by suction and the suspension is then gassed with carbogen for one minute ( repeating if necessary ) and incubated for 20 minutes at 37 ° c ., covered with aluminum foil , in an agitator at 200 cycles per minute . then the medium is cautiously removed with suction , the tissue is divided again using scissors and the tissue fragments are washed twice each with 10 ml isolation medium and then 5 ml digestion medium is again added to the tissue . after gassing with carbogen again for about one minute and incubating for 15 minutes at 37 ° c . in an agitator at 200 cycles per minute , the tissue fragments are divided by successively drawing out into a 10 ml , 5 ml , 2 ml and then a 1 ml glass pipette and pressed through a single layer of filter cloth . the cells isolated in this way are then washed five times in incubation medium ( 37 ° c . ), gassed with carbogen and centrifuged for 5 minutes each time at 90 g . the pellet obtained finally is resuspended in incubation medium , gassed and distributed on tissue culture dishes . the tissue culture dishes with the isolated cells are cultured in an incubator at 37 ° c . and 5 % co 2 . the medium is changed every 2 to 3 days , at which time all the differentiated cells are removed . on the 7 th day in the culture , the cells are passaged using a solution consisting of 2 ml pbs , 1 ml trypsin and 2 ml incubation medium . in the course of this , the cells are detaching from the bottom of the culture dish . the cell suspension is centrifuged for five minutes , the supernatant is removed with suction and the cells are resuspended in 2 ml incubation medium , transferred to a medium - sized cell culture flask and 10 ml incubation medium is added . the medium is changed every three days . on the 14 th day in culture , the cells are passaged again , but this time with 6 ml pbs , 3 ml trypsin and 6 ml incubation medium . the cell suspension is centrifuged for five minutes , the supernatant is removed with suction and the cells are resuspended in 6 ml incubation medium , transferred to three medium - sized cell culture flasks and 10 ml incubation medium is added to each . the cells are cultured further and passaged and seeded until the cells achieve a semiconfluent to confluent state . pancreatic acini were obtained from male sprague - dawley rats ( 20 to 300 g ) which had been anesthetized ( co 2 ) and exsanguinated through the dorsal aorta . a cannula was introduced transduodenally into the pancreatic duct and 10 ml digestion medium containing hepes eagle medium ( ph 7 . 4 ), 0 . 1 mm hepes buffer ( ph 7 . 6 ), 70 % ( v / v ) modified eagle medium , 0 . 5 % ( v / v ) trasylol ( bayer ag , leverkusen , germany ), 1 % ( w / v ) bovine serum albumin ), 2 . 4 mm cacl 2 and collagenase ( 0 . 63 p / mg , serva , heidelberg , germany ) was injected into the pancreas posteriorly . before removing the pancreas it was partially freed of adhering fatty tissue , lymph nodes and blood vessels . then healthy pancreatic tissue was placed in the digestion medium ( at 20 ° c ., lower metabolism ), the pancreatic tissue was divided very finely with scissors , fatty tissue floating at the top was removed with suction and the tissue suspension was gassed with carbogen ( messer , krefeld , germany ) without allowing the nozzle to enter the medium with the cells ( reducing mechanical stress ) and the ph was adjusted to 7 . 4 in this way . then the suspension was incubated at 37 ° c . in 10 ml digestion medium in a 25 ml erlenmeyer flask ( covered with aluminum foil ) while agitating constantly ( 150 to 200 cycles per minute ). after 15 to 20 minutes , the fat floating at the top and the medium were removed with suction and the tissue was divided again and rinsed with medium without collagenase ( repeating the process at least twice , preferably until the cell fraction became transparent ), whereupon digestion medium was added and the mixture was gassed again for about one minute with carbogen . digestion was again performed with collagenase for 15 minutes at 37 ° c . in an agitator using the same buffer . after digestion , the acini were dissociated by successively pulling up and ejecting through 10 ml , 5 ml and 2 ml glass pipettes with narrow openings and filtered through a single layer nylon mesh ( polymon pes - 200 / 45 , angst & amp ; pfister ag , zurich , switzerland ) with a mesh of approximately 250 μm . the acini were centrifuged ( at 37 ° c . and 600 to 800 rpm in a beckman gpr centrifuge corresponding to approximately 90 g ) and purified further by washing in incubation medium containing 24 . 5 mm hepes ( ph 7 . 5 ), 96 mm nacl , 6 mm kcl , 1 mm mgcl 2 , 2 . 5 mm nah 2 po 4 , 0 , mm cacl 2 , 11 . 5 mm glucose , 5 mm sodium pyruvate , 5 mm sodium glutamate , 5 mm sodium fumarate , 1 % ( v / v ) modified eagle medium , 1 % ( w / v ) bovine serum albumin , equilibrated with carbogen and adjusted to a ph of 7 . 4 . the washing procedure ( centrifugation , suction removal , resuspension ) was repeated five times . unless otherwise indicated , the isolation procedure described above was performed at approximately 20 ° c . the acini were resuspended in incubation medium and cultured at 37 ° c . in a humid atmosphere with 5 % co 2 . the acinar tissue died rapidly under these conditions ( within 2 days ) and the dying differentiated cells separated from the adjacent cells without damaging the latter ( gentle isolation ) while the non - dying stem cells sank to the bottom and attached themselves . the differentiated acini cells are not capable of doing this . the incubation medium was changed for the first time on the second or third day after inoculating , with most of the freely floating acini and acinar cells being removed . at this point the first stem cells or their precursors had attached themselves to the bottom and had begun to divide . then the medium was changed again every third day and differentiated acinar pancreatic cells were removed each time the medium was changed . on the seventh day in culture the cells were passaged with a solution consisting of 2 ml pbs , 1 ml trypsin (+ 0 . 05 % edta ) and 2 ml incubation medium , whereupon the cells detached from the bottom of the culture dish . the cell suspension was centrifuged for five minutes at about 1000 rpm ( beckmann gpr centrifuge ), the supernatant was removed with suction and the cells were resuspended in 2 ml incubation medium , transferred to a medium - sized cell culture flask and 10 ml incubation medium was added . on the 14 th day in culture , the cells again were passaged , but this time with 6 ml pbs , 3 ml trypsin / edta and 6 ml incubation medium . the cell suspension was centrifuged for 5 minutes at 1000 rpm , the supernatant was removed with suction and the cells were resuspended in 6 ml incubation medium , transferred to three medium - sized cell culture flasks and 10 ml incubation medium was added to each . on day 17 a third passage was performed on a total of six medium - sized cell culture flasks , and on day 24 a fourth passage was performed on a total of 12 medium - sized cell culture flasks . now at the latest all the primary cells were removed from the cell culture except for the stem cells . the stem cells may be cultured further , passages and inoculations being performed as frequently as desired . the inoculation is preferably performed in a density of 2 × 10 5 to 4 × 10 5 cells / cm 2 in incubation medium . isolation and culturing from exocrine tissue of the parotid gland of a human were performed by analogy with the pancreas protocol with the following deviations : 1 . the exocrine tissue of the parotid gland was a mixture of acinar tissue and tubular tissue . 2 . since salivary glands contain less proteases and amylases than the pancreas , it is possible to store the salivary glandular tissue for a while under refrigeration at about 4 ° c . before workup without damaging the tissue too much . in the concrete example , the storage time was 15 hours and did not have any negative effects with regard to isolation of the desired stem cells . example 4 below describes in detail a working protocol for producing organoid bodies . the undifferentiated cells are trypsinated with a solution of 10 ml pbs , 4 ml trypsin and 8 ml differentiation medium and then centrifuged off for five minutes . the resulting pellet is resuspended in differentiation medium so that a dilution of 3000 cells per 100 μl medium is established . then the cells are suspended again well with a 3 ml pipette . the cover is removed from bacteriological petri dishes that had previously been coated with 15 ml pbs ( 37 ° c .) per plate and the cover is inverted . using an automatic pipette , approximately fifty 20 μl drops are placed on each cover . the cover is then turned over rapidly and placed on the petri dish filled with differentiation medium so that the drops hang down . the petri dishes are then cautiously placed in the incubator and incubated for 48 hours . next the aggregated cells in the hanging drops , forming the organoid bodies , are transferred from four covers each into one bacteriological petri dish with 5 ml incubation medium with 20 % fcs and cultured for another 96 hours . the organoid bodies are then cautiously collected with a pipette and transferred to cell culture vessels holding differentiation medium and coated with 0 . 1 % gelatin . in an especially preferred embodiment of this method , 6 cm petri dishes coated with 0 . 1 % gelatin are used as the culture vessels ; 4 ml differentiation medium is placed in each in advance and then they are charged with six organoid bodies each . another preferred culture vessel consists of chamber slides coated with 0 . 1 % gelatin with 3 ml differentiation medium placed in each and then charged with three to eight organoid bodies each . in addition , 24 - well microtiter plates coated with 0 . 1 % gelatin with 1 . 5 ml differentiation medium placed in each well and then charged with four organoid bodies each may also be used . when cultured in this way , the ability of the cells to differentiate into organoid bodies is activated and the cells can differentiate in particular into cells of the ectoderm . the cells may be stored and cultured both as organoid bodies or as individual cells and they retain their pluripotency . the differentiation of cells in organoid bodies or tissue bodies can take place in general in a cultivation medium with an additive that influences the differentiation or on the boundary of a cultivation medium with a gaseous or vaporous environment . the following examples 5 and 6 describe working protocols for both variants . for induction of differentiation , preferably stem cells after the 42 nd day of culturing were used . it is also possible to use stem cells after the third or fourth passage or cells stored for 12 to 18 months at the temperature of liquid nitrogen with no problem . first the cells were transferred to differentiation medium having the composition given above and adjusted to a density of approximately 3 × 10 4 cells / ml , e . g ., by trypsin treatment of a stem cell culture in culture medium , centrifugation for 5 minutes at 1000 rpm and resuspending the pellet in differentiation medium and diluting as much as necessary . then using a 20 μl pipette , approximately fifty 20 μl drops ( 600 cells / 20 μl ) were placed on the inside of the cover of a bacteriological petri dish ( stoppered tip ) and the covers were cautiously inverted over the petri dishes filled with pbs so that the drops would hang down . a new tip was used for each cover . the petri dishes were then cautiously placed in the incubator and incubated for 48 hours at 37 ° c . next the aggregated cells in the hanging drops , i . e ., the organoid bodies , were transferred from four covers each into one bacteriological petri dish each with 5 ml incubation medium with 20 % fcs ( hold the cover obliquely and rinse off the organoid bodies with approximately 2 . 5 ml culture medium ) and then cultured for five to nine more days , preferably 96 hours . the organoid bodies were then collected cautiously using a pipette and transferred to cell culture vessels coated with 0 . 1 % gelatin and containing differentiation medium . the organoid bodies would then proliferate and grow into partly isolated cell colonies which could then be further proliferated , isolated and proliferated again . in an especially preferred embodiment of this method , 6 cm petri dishes which were coated with 0 . 1 % gelatin and into which 4 ml differentiation medium had already been placed were used as the culture vessels , each petri dish being charged with six organoid bodies . another preferred culture vessel was chamber slides coated with 0 . 1 % gelatin , into which 3 ml differentiation medium had been placed and which were then each charged with three to eight organoid bodies , and thermanox plates ( nalge nonc international , usa ) for electron micrographic studies . another alternative was 24 - well microtiter plates coated with 0 . 1 % gelatin with 1 . 5 ml differentiation medium placed in each well which was then charged with four organoid bodies each . in a preferred embodiment of this method , organoid bodies were cultured for about 7 weeks in the gelatin - coated 6 cm petri dishes and then individual organoid bodies were cut out using the microdissector ( eppendorf , hamburg , germany ) according to the manufacturer &# 39 ; s instructions and then transferred to fresh 6 cm petri dishes , chamber slides or thermanox plates , for example . fig5 shows by way of example a tissue body 5 growing in the adhesion culture ( the white line corresponds to a length of 2 mm in the original ), a part of the tissue body extending out of the cultivation medium . tissue body 5 grew out of an organoid body formed in accordance with one of the processes indicated above . epithelial cells 6 are generated in the part of tissue body 5 marked in dotted lines in the external air . plate epithelia are produced up to a size of several millimeters . fig6 illustrates light - and electronic microscopic views of differentiated epithelia ( the black line in the lowest image corresponds to a length of around 7 μm in the original ). fig7 illustrates further details of the process of the invention in the generation of epithelial cells on the liquid - solid border surface . the organoid bodies or tissue bodies produced in accordance with the process described above are deposited in step 310 on a cultivation substrate . the shifting of the liquid surface of the cultivation medium subsequently follows ( step 320 ) until the top of the organoid body or tissue body touches the liquid surface . the further differentiation of the cells takes place in at least one of the three illustrated ways , namely , by growing out of the cultivation medium ( step 321 ), by a lowering of the level of the cultivation medium ( step 322 ) and / or by a shifting of the cultivation substrate ( step 323 ). the epithelial cells generated are subsequently separated ( step 330 ) and devoted to a further propagation ( see step 400 in fig1 ). fig8 schematically shows important components of a cultivation device in accordance with the invention with a cultivation substrate 10 that is arranged in such a manner that it can be shifted and fixed in certain positions in cultivation vessel 20 . to this end positioning means 30 is provided as a controlling means with which cultivation substrate 10 can be positioned , e . g ., with a piezoelectric actuator . furthermore , filling level 21 of the cultivation liquid can be adjusted in cultivation vessel 20 with level control 40 comprising known fluidic components such as , e . g ., valves and a pump . sensor 22 is provided in order to monitor filling state 21 of the cultivation liquid in cultivation vessel 20 . sensor 22 is , e . g ., an optical sensor or a conductivity sensor with which the filling level can be detected in a known manner . the sensor signal can be used to actuate positioning means 30 and / or level control 40 within the framework of a control circuit . imprinting tool 50 with imprint surface 51 with which a certain form can be impressed on the epithelial cells forming on the surface of tissue body 5 is located above liquid surface 21 . the operation of the cultivation device takes place in accordance with the scheme in fig7 in such a manner that at first one or several tissue bodies 5 is / are deposited on cultivation substrate 10 . a growing out of tissue body 5 , a shifting of cultivation substrate 10 and / or an adjustment of filling level 21 until a part of tissue body 5 extends out of the cultivation medium and differentiates to epithelial cells subsequently take place . the use of imprinting tool 50 in accordance with fig8 is not obligatorily necessary . the shaping of the epithelial tissue can take place subsequently in the further propagation of the differentiated epithelial cells ( step 400 , see fig1 ). typical process steps of the further propagation are compiled in fig9 . the deposition of the differentiated epithelial cells on a deformation substrate ( step 410 ) takes place at first . the shifting of the substrate surface ( step 420 ) subsequently takes place so that the epithelial cells form a desired shape . this shifting may be combined with an additional shaping with an imprinting tool . finally , the separation of the epithelial body ( step 430 ) takes place . the deformation substrate , whose details are described with reference made to fig1 and 11 , serves for the reception and the growth of epithelial cells as well as their shaping . it may have a deformable surface itself and / or function as carrier of the epithelial cells during the action of a imprinting tool . fig1 illustrates a deformation substrate 60 including a plurality of forming elements 61 that can be shifted individually with positioning means 62 attached to a base part ( not shown ). each forming element 61 has an ashlar form with a top . the total number of tops or at least one flexible , layered cover element 63 arranged on the latter form the surface of deformation substrate 60 used for the shaping on epithelial composition 6 . the tops of forming elements 61 have typical dimensions in a range of 0 . 01 mm to 5 mm . forming elements 61 are aligned in such a manner that the tops form a matrix arrangement consisting of straight rows and columns . the shifting of forming elements 61 relative to the base part takes place , e . g ., with servomotors or piezoelectric drives . the surface is structured in accordance with the selected advance of a forming element 61 . covering element 63 has the advantages that the tool surface is locally smoothed and the removal of cell material 6 from the tool is facilitated . covering element 63 comprises , e . g ., a foil ( e . g ., polyurethane ) or a membrane that extends over all forming elements 61 and on which the cells are arranged . alternatively , one or more covering elements can be provided that extend only over one or several partial groups of forming elements . a detachable adhering of covering element 63 to some or all tops of forming elements 61 can be provided . covering element 63 may consist of a synthetic polymer material and / or of a material naturally occurring in biological organisms such as , e . g ., chitin or bone matrix material in one or more layers . furthermore covering element 63 may bear a structured coating that on the one hand promotes an adherent adhesion of biological cells in partial areas and on the other hand blocks it in other partial areas . in order to shape epithelial material 6 it is first arranged on the surface of deformation substrate 60 , that is , the totality of the tops or the common covering element 63 . to this end , e . g ., a deposit of a plurality of organoid bodies or tissue bodies is provided in cultivation medium 71 in culture vessel 70 . subsequently , a growth of the organoid bodies or tissue bodies and a shifting of the surface of deformation substrate 60 by advancing forming elements 61 into the particular desired positions take place . this advance takes place at the above - indicated molecular bonding rate of the cells so that the cells can be displaced and rearranged without injury during the deformation of the cell material . a separation of the cell material as epithelial bodies from deformation substrate 60 can subsequently take place . a deformation substrate according to fig1 may alternatively be used as imprinting tool 50 , as is illustrated in the image sequence according to fig1 . epithelial cell material 6 to be deformed is present in an initial situation according to partial image a on a support 80 . the imprinting tool 50 with the plurality of shiftable forming elements 51 is arranged above the surface of the cell material 6 that is free at first . the imprinting tool 50 is approached to the cell material 6 until the tops , that face downward in this instance , make contact with the cell material 6 . subsequently , an adjustment of the imprinting surface of the imprinting tool 50 takes place according to partial image b by the purposeful advance of individual forming elements 51 . the advancing movement takes place at the above - indicated molecular bonding rate of biological cells . the individual forming elements 51 displace the cells in the cell material without injury . subsequently , the imprinting tool 50 is removed according to partial image c . the surface form of the tool remains as a complementary structure in the cell material 6 . in order to facilitate the separation of the imprinting tool 50 from the cell material 6 the tops of the forming elements 51 can be provided with a coating to which an adherence of cells is prevented . the coating takes place , e . g ., with the polymer polyhema . finally , the gaps imprinted in the cell material can be filled according to partial image d with other cells 7 or a synthetic matrix material . the selection of the form and optionally of cells or additives 7 introduced into the cell material takes place in accordance with the concrete task within the framework of tissue engineering . for example , epithelial cells with a predetermined structure can be brought into a combination with tissue cells with a sequence according to fig1 . the features of the invention disclosed in the above description , the claims and the drawings can be significant individually as well as in combination for the realization of the invention in its various embodiments .
disclosed is a method for forming epithelial cells . said method comprises the steps of aggregating stem cells from differentiated exocrine gland tissue to obtain an organoid body and differentiating at least one portion of the organoid body or a tissue body grown therefrom to obtain epithelial cells . also disclosed is a cultivation device , particularly for forming differential epithelial cells .